FDA Inspection 1082722 — Sharplight Technologies
The FDA completed an inspection of Sharplight Technologies on Feb 14, 2019 in Rishon Le-Tsiyon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 14, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Radiation Control and Health Safety Act
- Location
- Rishon Le-Tsiyon (Israel)